Financial disclosure: M.L.S., N.G.B., L.M., D.W., Y.Y., and R.K. are employees of and/or own stock in Acceleron Pharma, Inc. K.K. is an employee of West Coast Clinical Trials. N.C. and A.L. are employees of and/or own stock in Celgene.
Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women
Article first published online: 9 SEP 2013
© 2013, The American College of Clinical Pharmacology
The Journal of Clinical Pharmacology
Volume 53, Issue 11, pages 1121–1130, November 2013
How to Cite
Sherman, M. L., Borgstein, N. G., Mook, L., Wilson, D., Yang, Y., Chen, N., Kumar, R., Kim, K. and Laadem, A. (2013), Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women. Journal of Clinical Pharma, 53: 1121–1130. doi: 10.1002/jcph.160
Results of this study were presented in part in abstract form at the 50th Annual Meeting of the American Society of Hematology (San Francisco, CA, USA; December 6–8, 2008); at the 2009 Joint Meeting of the International Society for Clinical Densitometry-International Osteoporosis Foundation (Orlando, FL, USA; March 11–14, 2009); at the 31st American Society for Bone and Mineral Research (Denver, CO, USA; September 11–15, 2009); and at the IX International Meeting on Cancer-Induced Bone Disease (Arlington, VA, USA; October 28–31, 2009).
- Issue published online: 5 OCT 2013
- Article first published online: 9 SEP 2013
- Accepted manuscript online: 12 AUG 2013 07:36AM EST
- Manuscript Accepted: 2 AUG 2013
- Manuscript Received: 14 MAR 2013
Additional supporting information may be found in the online version of this article at the publisher's web-site.
|jcph160-sm-0001-SuptTable-S1.doc||63K||Table SI. Subject Demographic and Baseline Characteristics (N = 31)|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.